FRED A. MIDDLETON - 25 Jun 2021 Form 4 Insider Report for CHIMERIX INC

Role: Director
Signature: /s/ Michael Alrutz, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 25 Jun 2021
Net transactions value: +$78,148
Form type: 4
Filing time: 29 Jun 2021, 17:37:18 UTC
Previous filing: 25 Jun 2021
Next filing: 20 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRX	Common Stock	Purchase	$23,729	+3,050	+1.5%	$7.78^*	200,573	25 Jun 2021	Direct
transaction	CMRX	Common Stock	Purchase	$54,418	+6,950	+3.5%	$7.83^*	207,523	28 Jun 2021	Direct
holding	CMRX	Common Stock						2,776,093	25 Jun 2021	See footnote	F1, F2
holding	CMRX	Common Stock						531,861	25 Jun 2021	See footnote	F2, F3
holding	CMRX	Common Stock						3,446	25 Jun 2021	See footnote	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities are held as follows: 829,046 shares of common stock held by Sanderling Venture Partners V, L.P., 233,134 shares of common stock held by Sanderling V Biomedical, L.P., 155,143 shares of common stock held by Sanderling V Limited Partnership, 138,046 shares of common stock held by Sanderling V Beteiligungs GmbH & Co. KG, 199,853 shares of common stock held by Sanderling V Biomedical Co-Investment Fund, L.P., 329,682 shares of common stock held by Sanderling Venture Partners V Co-Investment Fund, L.P. and 891,189 shares of common stock held by Sanderling V Strategic Exit Fund, L.P. (collectively, the Sanderling V Shares).
F2	The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling V Shares and the Sanderling VI Shares (as defined herein). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F3	The securities are held as follows: 498,046 shares of common stock held by Sanderling Venture Partners VI Co-Investment Fund, L.P., 15,431 shares of common stock held by Sanderling VI Beteiligungs GmbH & Co. KG and 18,384 shares of common stock held by Sanderling VI Limited Partnership (collectively, the Sanderling VI Shares).
F4	The securities are held by the Middleton-McNeil Retirement Trust, over which the reporting person shares voting and investment power. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.